These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27509719)

  • 1. [A Case of Heparin-Induced Thrombocytopenia with Discrepancy in the Results of Anti-Platelet Factor 4/Heparin Antibodies between Latex-Particle-Enhanced Immunoturbidimetric Assay and Enzyme Immunoassay].
    Yoshika M; Komiyama Y; Matsumoto H; Hirai M; Terauchi R; Nomura A; Maeba H; Imada T; Okura H; Kadosaka Y; Shiojima I; Takahashi H
    Rinsho Byori; 2014 Nov; 62(11):1047-51. PubMed ID: 27509719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Heparin-induced thrombocytopenia (HIT): pathogenesis, laboratory test, and treatment].
    Matsuo T; Wanaka K; Asada R
    Rinsho Byori; 2005 Jul; 53(7):622-9. PubMed ID: 16104531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Levels of antiplatelet factor 4-heparin antibodies and 4T score for heparin induced thrombocytopenia].
    Martinuzzo ME; Cerrato GS; Iglesias Varela ML; Adamczuk YP; Pombo G; Forastiero RR
    Medicina (B Aires); 2012; 72(1):19-22. PubMed ID: 22257451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
    Demma LJ; Winkler AM; Levy JH
    Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Egyptian experience of reliability of 4T's score in diagnosis of heparin induced thrombocytopenia syndrome.
    Tawfik NM; Hegazy MA; Hassan EA; Ramadan YK; Nasr AS
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):701-5. PubMed ID: 22008905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of automatized PF4/heparin immunoassays HemosIL HIT-ab (PF4-H) for the diagnosis of heparin-induced thrombocytopenia.
    Jourdy Y; Nougier C; Rugeri L; Bordet JC; Sobas F; Negrier C
    Int J Lab Hematol; 2015 Apr; 37(2):244-52. PubMed ID: 25041633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical-laboratory approach contributing to a rapid and reliable diagnosis of heparin-induced thrombocytopenia.
    Denys B; Stove V; Philippé J; Devreese K
    Thromb Res; 2008; 123(1):137-45. PubMed ID: 18582919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timely diagnosis and management of heparin-induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T's score and particle gel immunoassay.
    Bryant A; Low J; Austin S; Joseph JE
    Br J Haematol; 2008 Dec; 143(5):721-6. PubMed ID: 19036016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a flow cytometer-based functional assay using platelet-rich plasma in the diagnosis of heparin-induced thrombocytopenia.
    Althaus K; Pelzl L; Hidiatov O; Amiral J; Marini I; Bakchoul T
    Thromb Res; 2019 Aug; 180():55-61. PubMed ID: 31220752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrater agreement for two systems used to determine the probability of heparin-induced thrombocytopenia.
    Doré M; Frenette AJ; Chagnon I; Routhier N; Williamson D
    Am J Health Syst Pharm; 2014 Dec; 71(23):2045-52. PubMed ID: 25404596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A difficult diagnosis case of prolonged thrombocytopenia with sepsis and disseminated intravascular coagulation.
    Yoshika M; Komiyama Y; Hirakawa A; Nakatani T; Takahashi H
    Clin Appl Thromb Hemost; 2011 Aug; 17(4):410-3. PubMed ID: 20530051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Patient who developed heparin-induced thrombocytopenia type II after 24 years on hemodialysis].
    Gavranić BB; Basić-Jukić N; Kes P
    Acta Med Croatica; 2012 Oct; 66 Suppl 2():68-71. PubMed ID: 23513420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
    Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
    Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New approaches to the diagnosis of heparin-induced thrombocytopenia.
    Warkentin TE
    Chest; 2005 Feb; 127(2 Suppl):35S-45S. PubMed ID: 15706029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk of preexisting heparin-induced thrombocytopenia antibodies in patients with acute VTE.
    Warkentin TE; Davidson BL; Büller HR; Gallus A; Gent M; Lensing AWA; Piovella F; Prins MH; Segers AEM; Kelton JG
    Chest; 2011 Aug; 140(2):366-373. PubMed ID: 21393394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying patients at high risk of heparin-induced thrombocytopenia-associated thrombosis with a platelet activation assay using flow cytometry.
    Maeda T; Nakagawa K; Murata K; Kanaumi Y; Seguchi S; Kawamura S; Kodama M; Kawai T; Kakutani I; Ohnishi Y; Kokame K; Okazaki H; Miyata S
    Thromb Haemost; 2017 Jan; 117(1):127-138. PubMed ID: 27734072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
    Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
    Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biologic features of patients suspected or confirmed to have heparin-induced thrombocytopenia in a cardiothoracic surgical ICU.
    Trehel-Tursis V; Louvain-Quintard V; Zarrouki Y; Imbert A; Doubine S; Stéphan F
    Chest; 2012 Oct; 142(4):837-844. PubMed ID: 22406956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of clinical and laboratory data for early diagnosis of heparin-induced thrombocytopenia.
    Bayat M; Macedo FY; Ansari AS; Bracey AW; Akinyele S; Salazar M
    Am J Health Syst Pharm; 2015 Oct; 72(19):1649-55. PubMed ID: 26386106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry study.
    Schindewolf M; Steindl J; Beyer-Westendorf J; Schellong S; Dohmen PM; Brachmann J; Madlener K; Pötzsch B; Klamroth R; Hankowitz J; Banik N; Eberle S; Kropff S; Müller MM; Lindhoff-Last E
    Thromb Res; 2014 Jul; 134(1):29-35. PubMed ID: 24703295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.